D. Loeb, R. Hobbs, Amarachukwu Okoli
Dec 1, 2010
Citations
0
Influential Citations
26
Citations
Journal
Cancer
Abstract
Samarium‐153 ethylenediamine tetramethylene phosphoric acid (153Sm‐EDTMP) is a radiopharmaceutical that has been used to treat osteosarcoma. The authors conducted a phase 2 study to test safety and response of high‐risk osteosarcoma to tandem doses of 153Sm‐EDTMP and to determine correlation between radiation delivered by low and high administered activities.